🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SAN
$SANA
🔒 US EquitiesSana Biotechnology Inc
AVG HISTORICAL GAP
+1.54%
MAX GAP RECORD
+14.54%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SANA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SANA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE) |
+1.11%
|
| May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE) |
-1.12%
|
| Mar 03, 2026 Earnings Release 2026-03-03 (AFTER CLOSE) |
-2.29%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-3.46%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE) |
-0.68%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+2.35%
|
| Mar 17, 2025 Earnings Release 2025-03-17 (AFTER CLOSE) |
+2.53%
|
| Nov 08, 2024 Earnings Release 2024-11-08 (BEFORE OPEN) |
+1.94%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.4%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗